Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CMPI | PALI | ARCT | ||
| Company | Checkmate Pharmaceuticals Inc | Palisade Bio Inc | Arcturus Therapeutics Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.49 | 1.6600 | 7.79 | ||
| High | 10.50 | 1.6700 | 7.93 | ||
| Low | 10.48 | 1.5800 | 7.54 | ||
| Latest | 10.50 | 1.6000 | 7.67 | ||
| Change | +0.02 | -0.0300 | -0.30 | ||
| % Change | +0.19% | -1.84% | -3.76% | ||
| Volume | 63,600 | 2,258,800 | 409,600 | ||
| 20-Day Average Volume | 283,120 | 3,595,445 | 416,850 | ||
| Previous Close | 10.48 | 1.6300 | 7.97 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.43 | 1.6785 | 7.44 | ||
| 20-Day Raw Stochastic | 100.00% | 29.41% | 67.00% | ||
| 20-Day Relative Strength | 87.35 | 44.43 | 52.18 | ||
| Weighted Alpha | -59.50 | -25.76 | -50.83 | ||
| Today's Opinion | 100% Buy | 8% Buy | 40% Sell | ||
| Previous Opinion | 100% Buy | 8% Buy | 40% Sell | ||
| Last Month's Opinion | 88% Buy | 64% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.38% since 05/20/22 | -8.05% since 02/12/26 | +6.97% since 02/12/26 | ||
| Low | 10.47 on 05/23/22 | 1.5800 on 02/20/26 | 7.05 on 02/13/26 | ||
| High | 10.50 on 05/27/22 | 1.8400 on 02/13/26 | 8.00 on 02/19/26 | ||
| 1-Month | |||||
| %Chg | +1.06% since 04/27/22 | -15.34% since 01/20/26 | +8.03% since 01/20/26 | ||
| Low | 10.34 on 05/11/22 | 1.4500 on 01/30/26 | 7.00 on 02/05/26 | ||
| High | 10.50 on 05/27/22 | 1.9600 on 01/23/26 | 8.00 on 02/19/26 | ||
| 3-Month | |||||
| %Chg | +268.42% since 02/25/22 | -31.62% since 11/20/25 | +30.00% since 11/20/25 | ||
| Low | 2.41 on 04/18/22 | 1.4500 on 01/30/26 | 5.90 on 11/21/25 | ||
| High | 10.50 on 05/27/22 | 2.6400 on 12/30/25 | 8.00 on 02/19/26 | ||
| 6-Month | |||||
| %Chg | +193.30% since 11/26/21 | +122.25% since 08/20/25 | -55.82% since 08/20/25 | ||
| Low | 2.00 on 01/27/22 | 0.5300 on 09/11/25 | 5.85 on 11/20/25 | ||
| High | 10.50 on 05/27/22 | 2.6400 on 12/30/25 | 24.17 on 10/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 231,399 | 242,875 | 226,460 | ||
| Shares Outstanding, K | 22,038 | 149,003 | 28,414 | ||
| Annual Sales | 0 | 0 | 152,310,000 | ||
| Annual Net Income | -61,410,000 | -14,440,000 | -80,940,000 | ||
| Last Quarter Sales | 0 | 0 | 17,150,000 | ||
| Last Quarter Net Income | -15,870,000 | -2,870,000 | -13,450,000 | ||
| 60-Month Beta | -4.84 | 1.58 | 2.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 05/12/22 | -0.38 on 11/10/25 | -0.49 on 11/10/25 | ||
| Latest Earnings Date | 08/11/22 | 03/23/26 | 03/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 01/04/13 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||